Stress, Depression, and Neuroplasticity: A Convergence of Mechanisms
The DOI matches its Crossref record; 257 of the 257 references it cites were found in a registry or an index.
Abstract
Increasing evidence demonstrates that neuroplasticity, a fundamental mechanism of neuronal adaptation, is disrupted in mood disorders and in animal models of stress. Here we provide an overview of the evidence that chronic stress, which can precipitate or exacerbate depression, disrupts neuroplasticity, while antidepressant treatment produces opposing effects and can enhance neuroplasticity. We discuss neuroplasticity at different levels: structural plasticity (such as plastic changes in spine and dendrite morphology as well as adult neurogenesis), functional synaptic plasticity, and the molecular and cellular mechanisms accompanying such changes. Together, these studies elucidate mechanisms that may contribute to the pathophysiology of depression. Greater appreciation of the convergence of mechanisms between stress, depression, and neuroplasticity is likely to lead to the identification of novel targets for more efficacious treatments.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“current evidence indicates that impairment in growth factor signaling is associated with depressed mood (Pittenger and Duman 2008).”
From Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression (2018) · cites this paper as Pittenger and Duman 2008
In the citing paper
“neurotrophic growth factors and related signaling pathways constitute major players in neuroplasticity”
From Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression (2018) · cites this paper as Pittenger and Duman 2008
In the citing paper
“In addition, clean-cut evidence shows that antidepressants require neuroplasticity pathways to rescue the observed deficits in neuronal and synaptic plasticity often associated with mood disorders (Pittenger and Duman 2008).”
From Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression (2018) · cites this paper as Pittenger and Duman 2008
In the citing paper
“While traditional antidepressants acutely increase synaptic levels of monoamines, their chronic administration leads to changes in structural neuroplasticity that are contemporaneous with their clinical therapeutic effects (10–12).”
From Psychedelics and Other Psychoplastogens for Treating Mental Illness. (2021) · cites this paper as [10]
In the citing paper
“these changes in neural circuitry are believed to underlie the deficits in learning/memory, mood, motivation, and reward seeking that are characteristic of depression and related disorders (10, 67–74)”
From Psychedelics and Other Psychoplastogens for Treating Mental Illness. (2021) · cites this paper as [10]
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene
Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H., McClay, J., Mill, J., Martin, J., Braithwaite, A., et al. (2003) · Science · doi:10.1126/science.1083968 · Cited by 8,120 · cited 1×
“The relationship between psychosocial stressors and the development of depression in susceptible individuals has long been apparent (Kendler et al, 1999; Caspi et al, 2003).”
BackgroundNeurogenesis in the adult human hippocampus
Eriksson, P. S., Perfilieva, E., Björk-Eriksson, T., Alborn, A.-M., Nordborg, C., Peterson, D. A., & Gage, F. H. (1998) · Nature Medicine · doi:10.1038/3305 · Cited by 6,369
The Organization of Behavior; A Neuropsychological Theory.
Attneave, F., B., M., & Hebb, D. O. (1950) · The American Journal of Psychology · doi:10.2307/1418888 · Cited by 5,146
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321 · cited 1×
“As neurogenesis appears to be required for the behavioral response to antidepressants in rodents (Santarelli et al, 2003; see below) and impaired neurogenesis has been hypothesized to represent a core pathophysiological feature of major depression (Duman, 2004), this effect represents yet another…”
BackgroundSelf-citationThe Organization of Behavior: A Neuropsychological Theory
(1950) · Journal of the American Medical Association · doi:10.1001/jama.1950.02910470083028 · Cited by 4,195
Malenka, R. C., & Bear, M. F. (2004) · Neuron · doi:10.1016/j.neuron.2004.09.012 · Cited by 3,968
The molecular biology of memory storage: a dialogue between genes and synapses
Kandel, E. R. (2001) · Science · doi:10.1126/science.1067020 · Cited by 3,917 · cited 2×
“CREB, and other inducible transcription factors, induce effector genes that contribute to the stabilization of synaptic plasticity (Kandel, 2001).”
BackgroundEgan, M. F., Kojima, M., Callicott, J. H., Goldberg, T. E., Kolachana, B. S., Bertolino, A., Zaitsev, E., Gold, B., Goldman, D., Dean, M., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00035-7 · Cited by 3,888
Antidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766
Research works printed but not linked: 3
- American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental Disorders (DSM) IV-TR. American Psychiatric Press: Washington, DC.
- Nemeroff CB (2006). Use of atypical antipsychotics in refractory depression and anxiety. J Clin Psych 66 (S8): 13–21.
- O'Connor JJ, Rowan MJ, Anwyl R (1993). Naunyn Schmiedebergs Arch. Pharmacology 348: 158–163.
Cited by
Items 101–200 of 1,010
Hickie, I. B., Scott, E. M., Cross, S. P., Iorfino, F., Davenport, T. A., Guastella, A. J., Naismith, S. L., Carpenter, J. S., Rohleder, C., Crouse, J. J., et al. (2019) · Medical Journal of Australia · doi:10.5694/mja2.50383 · Cited by 208
Emotional consequences of neuropathic pain: Insight from preclinical studies
Yalcin, I., Barthas, F., & Barrot, M. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.08.002 · Cited by 196
Cell atrophy and loss in depression: reversal by antidepressant treatment
Banasr, M., Dwyer, J. M., & Duman, R. S. (2011) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2011.09.002 · Cited by 201
“Although cell atrophy and loss would appear to be difficult to repair, there is evidence that these deficits can be reversed or blocked by eliminating stress and treating depression [2,3].”
BackgroundInfluentialSelf-citationGuidotti, G., Calabrese, F., Anacker, C., Racagni, G., Pariante, C. M., & Riva, M. A. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2012.225 · Cited by 200
“Exposure to stress represents a major environmental contributor to the development of psychiatric conditions, such as major depression (Pittenger and Duman, 2008).”
BackgroundCreatine metabolism and psychiatric disorders: Does creatine supplementation have therapeutic value?
Allen, P. J. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.03.005 · Cited by 163
Peripheral Markers of Depression
Nobis, A., Zalewski, D., & Waszkiewicz, N. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9123793 · Cited by 197
Vulnerability to Depression: From Brain Neuroplasticity to Identification of Biomarkers
Blugeot, A., Rivat, C., Bouvier, E., Molet, J., Mouchard, A., Zeau, B., Bernard, C., Benoliel, J.-J., & Becker, C. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.1309-11.2011 · Cited by 189
“…concentrations (Sheline et al., 1999; Bremner et al., 2000; Shimizu et al., 2003; Karege et al., 2005; Czeh and Lucassen, 2007; Kim et al., 2007; Pittenger and Duman, 2008; Schmidt and Duman, 2010), could occur before the depressive state, thus constituting predictive markers of depression…”
BackgroundResultInfluentialCrocker, L. D., Heller, W., Warren, S. L., O'Hare, A. J., Infantolino, Z. P., & Miller, G. A. (2013) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2013.00261 · Cited by 193
“It also stimulates new synapse formation, strengthens synaptic connectivity, and alters neurotrophic signaling cascades (Manji et al., 2003; Pittenger and Duman, 2008; Andrade and Rao, 2010).”
BackgroundCellular and molecular mechanisms in the long-term action of antidepressants.
Racagni, G., & Popoli, M. (2008) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2008.10.4/gracagni · Cited by 192
“Among the CREB-regulated genes, BDNF is by far the one most thoroughly studied with regard to the mechanism of antidepressants and has lately become, together with CREB activation, a sort of readout system in the study of antidepressant mechanisms.(18,25,35-42) A result of this huge body of research in the last severa…”
BackgroundInfluentialHippocampal neuroplasticity in major depressive disorder
Malykhin, N. V., & Coupland, N. J. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.04.047 · Cited by 177
Cerniauskas, I., Winterer, J., de Jong, J. W., Lukacsovich, D., Yang, H., Khan, F., Peck, J. R., Obayashi, S. K., Lilascharoen, V., Lim, B. K., et al. (2019) · Neuron · doi:10.1016/j.neuron.2019.09.005 · Cited by 187
“Increasing evidence suggests that imbalances in glutamate transmission play a critical role in the development of depression (Pittenger and Duman, 2008; Thompson et al., 2015).”
BackgroundChakravarty, S., Reddy, B. R., Sudhakar, S. R., Saxena, S., Das, T., Meghah, V., Brahmendra Swamy, C. V., Kumar, A., & Idris, M. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063302 · Cited by 185
“During the last few decades, researchers using animal models have found that chronic stress can induce depression, anxiety and related mood disorders [2,3,6].”
BackgroundDepression research: where are we now?
Lee, S., Jeong, J., Kwak, Y., & Park, S. K. (2010) · Molecular Brain · doi:10.1186/1756-6606-3-8 · Cited by 170
“A recent study showed that CREB, a transcription factor that regulates expression of CRE-containing target genes including BDNF, is also upregulated and activated in hippocampus by chronic antidepressant treatment [2,53,68,69].”
BackgroundNADPH Oxidase Mediates Depressive Behavior Induced by Chronic Stress in Mice
Seo, J.-S., Park, J.-Y., Choi, J., Kim, T.-K., Shin, J.-H., Lee, J.-K., & Han, P.-L. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0794-12.2012 · Cited by 183
“Recent studies in stress-induced animal models, which do not presume or exclude the possibility that depression is caused by the depletion of monoaminergic activity, have shed light on the basis of depression, although stress-based animal models might mimic stress-triggered depression in humans (Pittenger and Duman, 2…”
BackgroundPeripheral whole blood microRNA alterations in major depression and bipolar disorder
Maffioletti, E., Cattaneo, A., Rosso, G., Maina, G., Maj, C., Gennarelli, M., Tardito, D., & Bocchio-Chiavetto, L. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.04.021 · Cited by 181
“…or, more recently, on the involvement of other biological pathways, particularly those regulating neurogenesis and neuroplasticity mechanisms (Pittenger and Duman, 2008), neuroimmune function (Müller and Schwarz, 2007) and glutamatergic neurotrasmission (Popoli et al., 2011) have been…”
BackgroundEpigenetic mechanisms of major depression: Targeting neuronal plasticity
Uchida, S., Yamagata, H., Seki, T., & Watanabe, Y. (2018) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12621 · Cited by 181
“Chronic stress increases the risk for depression.(64,65) In rodents, chronic stress affects the total levels of acetylated histones in certain limbic regions.”
BackgroundStephenson, D. T., O'Neill, S. M., Narayan, S., Tiwari, A., Arnold, E., Samaroo, H. D., Du, F., Ring, R. H., Campbell, B., Pletcher, M., et al. (2011) · Molecular Autism · doi:10.1186/2040-2392-2-7 · Cited by 180
“Reduced hippocampal neurogenesis is associated with stress, depression and defects in cognitive function [109]; the observation that stress abnormalities have been reported in BTBR mice [34] suggests a putative link.”
BackgroundHuang, Y., Coupland, N. J., Lebel, R. M., Carter, R., Seres, P., Wilman, A. H., & Malykhin, N. V. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.01.005 · Cited by 179
“Although the subiculum contributes a relatively small amount of volume to the hippocampus (26), anatomically it represents the main output of the hippocampal formation (9,59) and is likely a primary mode of hippocampal interactions with hypothalamic-pituitary-adrenal axis (59,60).”
BackgroundNoise trauma impairs neurogenesis in the rat hippocampus
Kraus, K. S., Mitra, S., Jimenez, Z., Hinduja, S., Ding, D., Jiang, H., Gray, L., Lobarinas, E., Sun, W., & Salvi, R. J. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.02.071 · Cited by 174
“…models of depression, neurogenesis is decreased and conversely, treatment with anti-depressant drugs increases neurogenesis (Kempermann 2002a, Campbell and Macqueen, 2004, Duman, 2004, Chen et al., 2006, Paizanis et al., 2007, Sahay et al., 2007, Vollmayr et al., 2007, Pittenger and Duman, 2008).”
BackgroundHill, M. N., Hillard, C. J., Bambico, F. R., Patel, S., Gorzalka, B. B., & Gobbi, G. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.06.006 · Cited by 172
Duman, C. H. (2010) · Vitamins and hormones · doi:10.1016/s0083-6729(10)82001-1 · Cited by 213
“This consideration has become increasingly important as mechanisms of neural plasticity are implicated as central to antidepressant effectiveness (Pittenger and Duman, 2008).”
Machado-Vieira, R., Manji, H. K., & Zarate, C. A. (2009) · The Neuroscientist · doi:10.1177/1073858409336093 · Cited by 171
Ebner, S. R., Roitman, M. F., Potter, D. N., Rachlin, A. B., & Chartoff, E. H. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1836-5 · Cited by 166
“1998) and with behaviors in rodents that are thought to reflect characteristics of depression, including a reduced ability to experience reward (anhedonia) and loss of motivation (Koob et al. 1989; Pittenger and Duman 2008).”
Anxiety, stress, and fear response in mice with reduced endocannabinoid levels
Jenniches, I., Ternes, S., Albayram, O., Otte, D. M., Bach, K., Bindila, L., Michel, K., Lutz, B., Bilkei-Gorzo, A., & Zimmer, A. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.03.033 · Cited by 169
Ma, K., Xu, A., Cui, S., Sun, M.-R., Xue, Y.-C., & Wang, J.-H. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.181 · Cited by 168
The molecular neurobiology of chronic pain–induced depression
Humo, M., Lu, H., & Yalcin, I. (2019) · Cell and Tissue Research · doi:10.1007/s00441-019-03003-z · Cited by 163
Psychedelics and Other Psychoplastogens for Treating Mental Illness.
Vargas, M. V., Meyer, R., Avanes, A. A., Rus, M., & Olson, D. E. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.727117 · Cited by 166
Tendolkar, I., van Beek, M., van Oostrom, I., Mulder, M., Janzing, J., Voshaar, R. O., & van Eijndhoven, P. (2013) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2013.09.004 · Cited by 161
Tchantchou, F., Lacor, P. N., Cao, Z., Lao, L., Hou, Y., Cui, C., Klein, W. L., & Luo, Y. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1189 · Cited by 162
“Various receptors and protein kinase pathways converge to regulate CREB activity, including NMDA receptors, serotonin receptors, and kinases such as cAMP-dependent protein kinase PKA, calmodulin dependent kinase CaMKII, and MAP kinases [22] that are required for LTP [23].”
BackgroundAnimal models of depression and anxiety: What do they tell us about human condition?
Neumann, I. D., Wegener, G., Homberg, J. R., Cohen, H., Slattery, D. A., Zohar, J., Olivier, J. D. A., & Mathé, A. A. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.11.028 · Cited by 160
“Gene×environment interactions were also found with respect to hippocampal neurogenesis, which has been shown to be stresssensitive and implicated in depression (Pittenger and Duman, 2008).”
Clinically Significant Drug Interactions with Newer Antidepressants
Spina, E., Trifirò, G., & Caraci, F. (2012) · CNS Drugs · doi:10.2165/11594710-000000000-00000 · Cited by 160
Chronic Stress Alters Striosome-Circuit Dynamics, Leading to Aberrant Decision-Making
Friedman, A., Homma, D., Bloem, B., Gibb, L. G., Amemori, K.-I., Hu, D., Delcasso, S., Truong, T. F., Yang, J., Hood, A. S., et al. (2017) · Cell · doi:10.1016/j.cell.2017.10.017 · Cited by 162
“These findings and other pioneering work demonstrates that the induction of dysfunctional neuronal circuitry due to prolonged environmental stress can deleteriously affect mental health (Lucassen et al., 2014; Pittenger and Duman, 2008; Selye, 1936; Sousa and Almeida, 2012).”
Patel, S., & Hillard, C. J. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06266.x · Cited by 162
“The development of animal models that recapitulate anxious and depressive symptoms, and associated physiological changes, has allowed for experimental investigations into the contributions of stress to mental illness and the mechanisms underlying stress adaptation (Pittenger & Duman, 2007).”
BackgroundBai, S., Dokos, S., Ho, K.-A., & Loo, C. K. A. (2013) · NeuroImage · doi:10.1016/j.neuroimage.2013.11.015 · Cited by 171
“In addition, several hypothetical montages were modelled: supraorbital–occipital (SO–OCC), premised on maximal stimulation of the sgACC and other central and midline subcortical structures; temporal–extracephalic (TMP–EC), prioritising temporal lobe stimulation as neurotrophic changes in this region may have a key rol…”
BackgroundGSK3β, CREB, and BDNF in peripheral blood of patients with Alzheimer's disease and depression
Pláteník, J., Fišar, Z., Buchal, R., Jirák, R., Kitzlerová, E., Zvěřová, M., & Raboch, J. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.12.001 · Cited by 161
“In addition to TrkB, a low-affinity p75 neurotrophin receptor is also involved in neuronal survival and plasticity (Hashimoto, 2010; Pittenger and Duman, 2008).”
BackgroundInsights into the biological functions of Dock family guanine nucleotide exchange factors
Laurin, M., & Côté, J.-F. (2014) · Genes & Development · doi:10.1101/gad.236349.113 · Cited by 160
Kim, Y., & Won, E. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.04.020 · Cited by 170
Endocrine substrates of cognitive and affective changes during pregnancy and postpartum.
Workman, J. L., Barha, C. K., & Galea, L. A. M. (2012) · Behavioral Neuroscience · doi:10.1037/a0025538 · Cited by 148
Hippocampal MicroRNA-124 Enhances Chronic Stress Resilience in Mice
Higuchi, F., Uchida, S., Yamagata, H., Abe-Higuchi, N., Hobara, T., Hara, K., Kobayashi, A., Shintaku, T., Itoh, Y., Suzuki, T., et al. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.0319-16.2016 · Cited by 158
“Previous studies reported that chronic stress episodes induced dendritic remodeling in rodent hippocampus that was reversed by antidepressants (Watanabe et al., 1992; Pittenger and Duman, 2008; Gray et al., 2013; Chattarji et al., 2015; McEwen et al., 2016).”
BackgroundRole of calcium, glutamate and NMDA in major depression and therapeutic application
Deutschenbaur, L., Beck, J., Kiyhankhadiv, A., Mühlhauser, M., Borgwardt, S., Walter, M., Hasler, G., Sollberger, D., & Lang, U. E. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.02.015 · Cited by 171
Chronic Stress- and Sex-Specific Neuromorphological and Functional Changes in Limbic Structures
McLaughlin, K. J., Baran, S. E., & Conrad, C. D. (2009) · Molecular Neurobiology · doi:10.1007/s12035-009-8079-7 · Cited by 174
“disorders [135–138].”
Remodeling of axo-spinous synapses in the pathophysiology and treatment of depression
Licznerski, P., & Duman, R. S. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2012.09.057 · Cited by 157
“Strong evidence of altered spine morphology and function in MDD is also provided by preclinical studies of stress and depression (McEwen, 2008; Pittenger and Duman, 2008; McEwen and Gianaros, 2011).”
Self-citationDendritic spine dynamics--a key role for kalirin-7
Penzes, P., & Jones, K. A. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.06.001 · Cited by 157
Liu, W., Wang, J., Xie, Z.-M., Xu, N., Zhang, G.-F., Jia, M., Zhou, Z., Hashimoto, K., & Yang, J. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4128-2 · Cited by 169
“…with sodium pentobarbital, and a single guide cannula was implanted into the lateral ventricle [coordinates relative to bregma −0.9 mm anteroposterior (AP), −1.5 mm mediolateral (ML), and −3.3 mm dorsoventral (DV) from dura, fixing with aluminium screws and dental cement] (Paxinos and Watson 1998).”
InfluentialMa, T., Jin, H., Kwok, L.-Y., Sun, Z., Liong, M.-T., & Zhang, H. (2021) · Neurobiology of Stress · doi:10.1016/j.ynstr.2021.100294 · Cited by 152
“Stress is a ubiquitous part of human daily life, it can cause anxiety and even depression in serious cases (Pittenger and Duman, 2008).”
BackgroundBranchi, I. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.08.011 · Cited by 156
“The findings showing that neural plasticity is, on the one hand, significantly reduced in depressed patients and, on the other hand, enhanced by antidepressant drugs suggest that an impairment in neural plasticity plays a role in determining vulnerability to depression (Duman et al., 2000; Manji et al., 2001; Fuchs et…”
BackgroundChen, F., Madsen, T. M., Wegener, G., & Nyengaard, J. R. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.12.007 · Cited by 166
“…© 2009 Published by Elsevier B.V. doi:10.1016/j.euroneuro.2008.12.007 w w w. e l s e v i e r. c o m / l o c a t e / e u r o n e u r o European Neuropsychopharmacology (2009) xx, xxx–xxx ARTICLE IN PRESS counteract the structural impairments (Pittenger and Duman, 2008; McEwen, 2000; Duman, 2004).”
InfluentialDale, E., Pehrson, A. L., Jeyarajah, T., Li, Y., Leiser, S. C., Smagin, G., Olsen, C. K., & Sanchez, C. (2016) · CNS Spectrums · doi:10.1017/s1092852915000425 · Cited by 148
“127 128 – 132 Interestingly, exposure to stress also impairs LTP in the CA1 and DG regions of the hippocampus (reviewed by Pittenger et al 133 and Popoli et al 134 ).”
Brain Neuroplasticity Leveraging Virtual Reality and Brain–Computer Interface Technologies
Drigas, A. S., & Sideraki, A. (2024) · Sensors · doi:10.3390/s24175725 · Cited by 205
Pouladi, M. A., Graham, R. K., Karasinska, J. M., Xie, Y., Santos, R. D., Petersen, A., & Hayden, M. R. (2008) · Brain · doi:10.1093/brain/awp006 · Cited by 145
The role of stress in the pathogenesis and maintenance of obsessive-compulsive disorder
Adams, T. G., Kelmendi, B., Brake, C. A., Gruner, P., Badour, C. L., & Pittenger, C. (2018) · Chronic Stress · doi:10.1177/2470547018758043 · Cited by 100
“Both preclinical and human studies of the effects of stress on the brain support this idea.(116) Preclinical work suggests that stress-induced structural and functional changes in corticostriatal and limbic circuits shift the balance between habitual and goal-directed behaviors.”
BackgroundSelf-citationPatel, S., Kingsley, P. J., Mackie, K., Marnett, L. J., & Winder, D. G. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.101 · Cited by 153
“Environmental and psychological stressors can recapitulate biochemical, structural, and behavioral aspects of depressive illness in laboratory animals (see Pittenger and Duman, 2008 for review).”
Serum markers support disease-specific glial pathology in major depression
Schroeter, M. L., Abdul-Khaliq, H., Krebs, M., Diefenbacher, A., & Blasig, I. E. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.03.005 · Cited by 152
“Mood disorders – once considered ‘good prognosis diseases’ – have, in fact, less favorable outcome than previously thought (Manji et al., 2000; Pittenger and Duman, 2007).”
BackgroundInflammation and neuronal plasticity: a link between childhood trauma and depression pathogenesis
Cattaneo, A., Macchi, F., Plazzotta, G., Veronica, B., Bocchio-Chiavetto, L., Riva, M. A., & Pariante, C. M. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00040 · Cited by 152
“…cytokines can access the brain, influence central neuronal functions and cause behavioral changes known as “sickness behavior”, a coordinated set of psychological and physiological modifications that develop during the course of an infection (Dantzer, 2004) and that resemble depressive symptoms.”
BackgroundIntegrated Metabolomics and Proteomics Analysis of Hippocampus in a Rat Model of Depression
Zhang, Y., Yuan, S., Pu, J., Yang, L., Zhou, X., Liu, L., Jiang, X., Zhang, H., Teng, T., Tian, L., et al. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.12.001 · Cited by 161
GABAergic Control of Depression-Related Brain States
Luscher, B., & Fuchs, T. (2015) · Advances in Pharmacology · doi:10.1016/bs.apha.2014.11.003 · Cited by 149
“Stress (Pittenger & Duman, 2008) and current antidepressant treatments (Kucukibrahimoglu et al., 2009; Maes, Verkerk, Vandoolaeghe, Lin, & Scharpe, 1998) are known to impact the glutamate system and, perhaps most informative, the discovery of antidepressant properties of the NMDA receptor…”
BackgroundDeep brain stimulation for treatment-resistant depression: Efficacy, safety and mechanisms of action
Anderson, R. J., Frye, M. A., Abulseoud, O. A., Lee, K. H., McGillivray, J. A., Berk, M., & Tye, S. J. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.06.001 · Cited by 135
Emerging role of CaMKII in neuropsychiatric disease
Robison, A. J. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2014.07.001 · Cited by 160
Chan, Y.-Y., Lo, W.-Y., Yang, S.-N., Chen, Y.-H., & Lin, J.-G. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.01.048 · Cited by 148
“, 2009), alterations of the hypothalamic–pituitary–adrenal (HPA) axis (Pariante and Lightman, 2008), changes in neuroplasticity (Pittenger and Duman, 2008) and gene expression alterations (Hepgul et al.”
BackgroundSales, A. J., Biojone, C., Terceti, M. S., Guimarães, F. S., Gomes, M. V., & Joca, S. R. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01489.x · Cited by 147
“…such as atrophy of apical dendrites, increased cell death and decreased neurogenesis, have been consistently found in stressed animals and humans (Pittenger and Duman, 2008; Lucassen et al., 2010; McEwen, 2010), and are suggested to contribute to the hippocampal dysfunction described in…”
BackgroundNeurobiology and systems biology of stress resilience
Kalisch, R., Russo, S. J., & Müller, M. B. (2024) · Physiological Reviews · doi:10.1152/physrev.00042.2023 · Cited by 166
Rugulies, R., Sørensen, K., Tecco, C. D., Bonafede, M., Rondinone, B. M., Ahn, S., Ando, E., Ayuso‐Mateos, J. L., Cabello, M., Descatha, A., et al. (2021) · Environment International · doi:10.1016/j.envint.2021.106629 · Cited by 154
Dysfunctional hippocampal activity affects emotion and cognition in mood disorders
Femenía, T., Gómez-Galán, M., Lindskog, M., & Magara, S. (2012) · Brain Research · doi:10.1016/j.brainres.2012.03.053 · Cited by 143
Spatially resolved mapping of cells associated with human complex traits
Song, L., Chen, W., Hou, J., Guo, M., & Yang, J. (2025) · Nature · doi:10.1038/s41586-025-08757-x · Cited by 178
Hou, Y., Aboukhatwa, M. A., Lei, D.-L., Manaye, K., Khan, I., & Luo, Y. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.11.002 · Cited by 141
“Glutamate stimulates CREB phosphorylation via several distinct signaling pathways (Shaywitz and Greenberg, 1999), including cAMP/PKA pathway (Chain et al., 1999; Vitolo et al., 2002; Matsuzaki et al., 2006), RAS/MAPK pathway and CaMK pathway (Dineley et al., 2001; Pittenger and Duman, 2008).”
BackgroundNovel Therapeutic Targets in Depression and Anxiety: Antioxidants as a Candidate Treatment
Xu, Y., Wang, C., Klabnik, J., & O' Donnell, J. (2014) · Current Neuropharmacology · doi:10.2174/1570159x11666131120231448 · Cited by 138
“There is a large body of evidence that antidepressants can increase activity of signaling pathways related to antioxidant effects; neuroplasticity by upregulation of cAMP/PKA/CREB cascade, regulation of CaMKII activity and upregulation of the MAPK cascade are choice examples [72].”
Molecular aspects of depression: A review from neurobiology to treatment
Villas Boas, G. R., Boerngen de Lacerda, R., Paes, M. M., Gubert, P., Almeida, W. L. D. C., Rescia, V. C., de Carvalho, P. M. G., de Carvalho, A. A. V., & Oesterreich, S. A. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.02.024 · Cited by 128
BDNF promoter methylation and genetic variation in late-life depression
Januar, V, Ancelin, M.-L., Ritchie, K., Saffery, R., & Ryan, J. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.114 · Cited by 139
Dwyer, J. M., & Duman, R. S. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.11.011 · Cited by 132
Self-citationMcKernan, D. P., Dinan, T. G., & Cryan, J. F. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.04.006 · Cited by 147
“Similar effects are also seen in animal models of chronic stress (reviewed in Pittenger and Duman, 2008) where there is hippocampal cell loss, atrophy and retraction of hippocampal apical dendrites, decreases in neurogenesis (Watanabe et al., 1992; Magarinos et al., 1996) and reduction in the…”
BackgroundInfluentialUnfolding the Role of BDNF as a Biomarker for Treatment of Depression
Rana, T., Behl, T., Sehgal, A., Srivastava, P., & BUNGAU, S. G. (2020) · Journal of Molecular Neuroscience · doi:10.1007/s12031-020-01754-x · Cited by 147
“2008; Pittenger and Duman 2008).”
BackgroundRobb, A. S., Cueva, J. E., Sporn, J., Yang, R., & Vanderburg, D. G. (2010) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2009.0115 · Cited by 132
“A growing body of research suggests that traumatic stress in adults is neurotoxic and is associated with deficits in hippocampal function and reduction in hippocampal volume (Smith 2005; Bremner et al. 2008; Pittenger and Duman 2008).”
Molecular Pharmacology and Neurobiology of Rapid-Acting Antidepressants
Gould, T. D., Zarate, C. A., & Thompson, S. M. (2019) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010617-052811 · Cited by 133
Andrade, C., & Rao, N. K. (2010) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.74318 · Cited by 120
“The increase is not merely structural; it is functional as well.[3] A recent meta-analysis of 13 MRI studies of the amygdala in unipolar depression however found that amgydalar volume increase was a function of antidepressant treatment.”
InfluentialAmpuero, E., Rubio, F. J., Falcon, R., Sandoval, M., Diaz-Veliz, G., Gonzalez, R. E., Earle, N., Dagnino-Subiabre, A., Aboitiz, F., Orrego, F., et al. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.04.035 · Cited by 132
Antidepressants act directly on astrocytes: Evidences and functional consequences
Czéh, B., & Benedetto, B. D. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.04.017 · Cited by 144
“This could be an underlying molecular mechanism contributing to the putative role of antidepressant to restore ‘‘aberrant’’ neuronal networks (Manji et al., 2003; Berton and Nestler, 2006; Pittenger and Duman, 2008; Krishnan and Nestler, 2010).”
BackgroundHow could stress lead to major depressive disorder?
Richter-Levin, G., & Xu, L. (2018) · IBRO Reports · doi:10.1016/j.ibror.2018.04.001 · Cited by 120
Wada, A. (2009) · Journal of Pharmacological Sciences · doi:10.1254/jphs.09r02cr · Cited by 128
Review of Pharmacological Treatment in Mood Disorders and Future Directions for Drug Development
Li, X., Frye, M. A., & Shelton, R. C. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.198 · Cited by 146
“The major mood disordersFbipolar disorder (acute mania and bipolar depression) and major depressive disorderF represent a spectrum of brain disorders with multiple etiologies, including genetic vulnerability, environmental stress, dysregulation of neurotransmission, abnormal neuroplasticity, and altered gene expressio…”
BackgroundMolteni, R., Calabrese, F., Cattaneo, A., Mancini, M., Gennarelli, M., Racagni, G., & Riva, M. A. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.208 · Cited by 142
“These alterations, which affects systems and pathways defective in mood disorders, are thought to contribute to their therapeutic activity (Duman, 2002; Pittenger and Duman, 2008).”
BackgroundHenningsen, K., Palmfeldt, J., Christiansen, S., Baiges, I., Bak, S., Jensen, O. N., Gregersen, N., & Wiborg, O. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.016428 · Cited by 125
Molteni, R., Cattaneo, A., Calabrese, F., Macchi, F., Olivier, J. D. A., Racagni, G., Ellenbroek, B. A., Gennarelli, M., & Riva, M. A. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.12.014 · Cited by 128
“During the last decade, the idea of major depression as a condition characterized by impaired neuronal plasticity has been developed, suggesting that psychopathology may be associated with reduced expression and function of proteins that are important for cellular resilience, leading to enhanced vulnerability under “c…”
InfluentialRiga, D., Kramvis, I., Koskinen, M. K., van Bokhoven, P., van der Harst, J. E., Heistek, T. S., Jaap Timmerman, A., van Nierop, P., van der Schors, R. C., Pieneman, A. W., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aai8753 · Cited by 128
“In line with this, preclinical models of depression using acute stress consistently show hippocampal pathology, including reduced hippocampal long-term potentiation (LTP) and impaired hippocampus-mediated spatial learning (8, 9).”
BackgroundDepression pathogenesis and treatment: what can we learn from blood mRNA expression?
Hepgul, N., Cattaneo, A., Zunszain, P. A., & Pariante, C. M. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-28 · Cited by 127
“Alterations in the expression of genes involved in neuroplasticity MDD may also involve an inability of neuronal systems, especially under stress conditions, to show adaptive plasticity, a mechanism known as neuronal plasticity [4] (see Table 3).”
BackgroundMolecular Mechanisms of Psilocybin and Implications for the Treatment of Depression
Ling, S., Ceban, F., Lui, L. M. W., Lee, Y., Teopiz, K. M., Rodrigues, N. B., Lipsitz, O., Gill, H., Subramaniapillai, M., Mansur, R. B., et al. (2022) · CNS Drugs · doi:10.1007/s40263-021-00877-y · Cited by 127
Neuroplasticity in Depressed Individuals Compared with Healthy Controls
Player, M. J., Taylor, J. L., Weickert, C. S., Alonzo, A., Sachdev, P., Martin, D., Mitchell, P. B., & Loo, C. K. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.126 · Cited by 127
“…is a state phenomenon is supported by improvements in indirect measures of neuroplasticity, such as learning and memory, while patients are in remission (Gallgher et al, (2007) and also after antidepressant treatment in humans and in animal models of depression (Pittenger and Duman, 2008).”
BackgroundInfluentialWang, W., Sun, D., Pan, B., Roberts, C. J., Sun, X., Hillard, C. J., & Liu, Q.-S. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.99 · Cited by 137
“There is an emerging concept that neuroplasticity has an important role in the pathophysiology of stress and depression and in the action of antidepressants (Pittenger and Duman, 2008).”
BackgroundZhang, Y., Shao, F., Wang, Q., Xie, X., & Wang, W. (2017) · Neural Plasticity · doi:10.1155/2017/9382797 · Cited by 124
Borrow, A. P., & Cameron, N. M. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.05.009 · Cited by 148
D-serine as a gliotransmitter and its roles in brain development and disease
Horn, M. R. V., Sild, M., & Ruthazer, E. S. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00039 · Cited by 143
“Chronically stressed animals, considered to be a model for depression, exhibit profound changes in neuroplasticity, specifically impairment in hippocampal and prefrontal cortical LTP induction, and a facilitation of spike-timing dependent long-term depression (Shors et al., 1990; Shors, 2004; Pittenger and Duman, 2008…”
BackgroundPCOS and Depression: Common Links and Potential Targets
Kolhe, J. V., Chhipa, A. S., Butani, S., Chavda, V. K., & Patel, S. S. (2021) · Reproductive Sciences · doi:10.1007/s43032-021-00765-2 · Cited by 139
Stress, the cortisol awakening response and cognitive function
Law, R. J., & Clow, A. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.01.001 · Cited by 141
Duman, C. H., Schlesinger, L., Terwilliger, R., Russell, D. S., Newton, S. S., & Duman, R. S. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.11.016 · Cited by 123
“A loss of neurotrophic support could contribute to atrophy and loss of neurons observed in pre-clinical models, as well as volumetric and cellular abnormalities reported in postmortem studies of depressed patients [7,41,47].”
BackgroundSelf-citationTransient stimulation with psychoplastogens is sufficient to initiate neuronal growth
Ly, C., Greb, A. C., Vargas, M. V., Duim, W. C., Grodzki, A. C. G., Lein, P. J., & Olson, D. E. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00065 · Cited by 123
MacKenzie, G., & Maguire, J. (2015) · Epilepsy Research · doi:10.1016/j.eplepsyres.2014.10.003 · Cited by 119
Dysfunctional astrocytic regulation of glutamate transmission in a rat model of depression
Gómez‐Galán, M., Bundel, D. D., Eeckhaut, A. V., Smolders, I. J., & Lindskog, M. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.10 · Cited by 134
Suggested Biomarkers for Major Depressive Disorder
Hacimusalar, Y., & Esel, E. (2017) · Noro Psikiyatri Arsivi · doi:10.5152/npa.2017.19482 · Cited by 113
Reckweg, J. T., Uthaug, M. V., Szabó, A., Davis, A. K., Lancelotta, R., Mason, N. L., & Ramaekers, J. G. (2022) · Journal of Neurochemistry · doi:10.1111/jnc.15587 · Cited by 134
“…that decreased neuroplasticity and neural atrophy in the prefrontal cortex (PFC) play an essential role in the general pathophysiology of these disorders (Duman & Aghajanian, 2012; Duman et al., 2016; Izquierdo et al., 2006; Pittenger & Duman, 2008; Russo & Nestler, 2013; Qiao et al., 2016).”
BackgroundSartori, C. R., Vieira, A. S., Ferrari, E. M., Langone, F., Tongiorgi, E., & Parada, C. A. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.02.055 · Cited by 140
“These drawbacks justify a great effort for the development of more effective treatments (Berton and Nestler, 2006; Hunsberger et al., 2007; Agid et al., 2007; Krishnan and Nestler, 2008; Mathew et al., 2008; Pittenger and Duman, 2008).”
Fischell, J., Van Dyke, A. M., Kvarta, M. D., LeGates, T. A., & Thompson, S. M. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.112 · Cited by 122
Metadata
- Authors
- Pittenger, C., & Duman, R. S.
- Affiliations
- Yale University (US)
- Corresponding author
- Duman, Ronald S
- Venue
- Neuropsychopharmacology
- Published
- 2007-09-12
- Volume
- 33
- Issue
- 1
- Pages
- 88-109
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W1978891587
- Cited by
- 1,795
- References
- 257
- Citations by year
- 2026: 48 · 2025: 77 · 2024: 83 · 2023: 73 · 2022: 98 · 2021: 137 · 2020: 107 · 2019: 95 · 2018: 97 · 2017: 105 · 2016: 97 · 2015: 99 · 2014: 112 · 2013: 108 · 2012: 147
- FWCI
- 6.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- chronic stress, depression, neuroplasticity, antidepressants, structural plasticity, adult neurogenesis, synaptic plasticity, dendritic spine morphology, mood disorders, animal models of stress, depression pathophysiology
- MeSH terms
- Animals, Depression, Humans, Learning Disabilities, Memory Disorders, Models, Neurological, Neuronal Plasticity, Neurons, Stress, Physiological, Signal Transduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.